Organigram Global Inc. (NASDAQ:OGI) is among the 7 Best Cannabis Stocks to Invest In Now.
Organigram Global Inc. (NASDAQ:OGI) reported Q1 revenue of $97.3 million, exceeding the $73.15 million consensus, based on a February 10, 2026, TheFly report. Adjusted EBITDA was $5.3 million, up from $1.4 million in the previous year. The corporation reported higher profits and solid revenue growth over the previous year. Higher flower yields, synergies from the Motif integration, more international sales, and operational efficiency all contributed to the adjusted gross margin’s sustained growth. The company anticipates continued international revenue growth in fiscal 2026.
Canaccord began covering the stock on January 27, 2026, with a C$3 price target and a Buy rating. The corporation stated that despite structural inefficiencies and legal obstacles, the Canadian cannabis market continues to be a global benchmark. Organigram Global Inc. (NASDAQ:OGI), the market leader in pre-rolls, extracts, and milled flower, is speeding up its shift to become a globally integrated, vertically integrated cannabis corporation.
Organigram Global Inc. (NASDAQ:OGI) provides high-quality, indoor-grown cannabis to patients and adult recreational customers. It also seeks international business alliances to expand the company’s global presence.
While we acknowledge the potential of OGI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 20 Best AI Stock To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None.
